Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients - EurekAlert

Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients  EurekAlert

Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who had EGFR-mutant ...